BOAN BIOTECH (06955) announced on August 28 that it repurchased 2 million shares for a total cost of HK$7.471 million.
The buyback transaction was executed at a per-share price ranging from HK$3.625 to HK$3.76, reflecting the company's ongoing capital management strategy.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.